Header Logo

JENNY VU POZADZIDES

TitleAssistant Professor
InstitutionMD Anderson
DepartmentGeneral Oncology
Address17450 St Lukes Way
Woodlands TX 77384
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pan K, Owens J, Elamin Y, Lu C, Routbort M, Zhang J, Fossella F, Negrao MV, Altan M, Pozadzides J, Skoulidis F, Tsao A, Cascone T, Heymach JV, Ostrin E, Le X, Pan K, Owens J, Elamin Y, Lu C, Routbort M, Zhang J, Fossella F, Negrao MV, Altan M, Pozadzides J, Skoulidis F, Tsao A, Cascone T, Heymach JV, Ostrin E, Le X. Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations. J Thorac Oncol. 2024 Oct; 19(10):1438-1448. PMID: 38866326.
      Citations: 1     Fields:    Translation:Humans
    2. Wang K, Du R, Myall NJ, Lewis WE, Uy N, Hong L, Skoulidis F, Byers LA, Tsao A, Cascone T, Pozadzides J, Tu J, Negrao MV, Gibbons DL, Park K, Rinsurongkawong W, Lee JJ, Gandara D, Behl D, Shu CA, Riess JW, Baik C, Wakelee HA, Vaporciyan AA, Heymach JV, Zhang J, Le X. Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC. J Thorac Oncol. 2024 03; 19(3):500-506. PMID: 38012986.
      Citations:    Fields:    Translation:Humans
    3. Chang JY, Lin SH, Dong W, Liao Z, Gandhi SJ, Gay CM, Zhang J, Chun SG, Elamin YY, Fossella FV, Blumenschein G, Cascone T, Le X, Pozadzides JV, Tsao A, Verma V, Welsh JW, Chen AB, Altan M, Mehran RJ, Vaporciyan AA, Swisher SG, Balter PA, Fujimoto J, Wistuba II, Feng L, Lee JJ, Heymach JV. Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial. Lancet. 2023 09 09; 402(10405):871-881. PMID: 37478883; PMCID: PMC10529504.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    4. Lewis DJ, Falck BA, Kantrow SM, Pozadzides JV, Hinojosa T, Huang S, Diwan AH, Prieto VG, Duvic M. Necrotizing Granulomatous Dermatitis and Panniculitis Masquerading as T Cell Lymphoma. Skinmed. 2019; 17(6):406-408. PMID: 31904333.
      Citations: 1     Fields:    Translation:Humans
    5. Jahan-Tigh RR, Huen AO, Lee GL, Pozadzides JV, Liu P, Duvic M. Hydrochlorothiazide and cutaneous T cell lymphoma: prospective analysis and case series. Cancer. 2013 Feb 15; 119(4):825-31. PMID: 22952039.
      Citations: 16     Fields:    Translation:Humans
    6. Pozadzides JV, Pro B. Hepatosplenic T-cell lymphoma and TNF-a inhibitors. Expert Rev Hematol. 2009 Dec; 2(6):611-4. PMID: 21082951.
      Citations: 5     Fields:    Translation:Humans
    7. Overman MJ, Pozadzides J, Kopetz S, Wen S, Abbruzzese JL, Wolff RA, Wang H. Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. Br J Cancer. 2010 Jan 05; 102(1):144-50. PMID: 19935793; PMCID: PMC2813754.
      Citations: 48     Fields:    Translation:HumansCells
    8. Talpur R, Vu J, Bassett R, Stevens V, Duvic M. Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata. J Am Acad Dermatol. 2009 Oct; 61(4):592.e1-9. PMID: 19682769.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    9. Duvic M, Vu J. Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat. Biologics. 2007 Dec; 1(4):377-92. PMID: 19707308; PMCID: PMC2721288.
      Citations: 19     
    10. Vu J, Bangert S, Hebert AA. Skin cancer presenting as a nonhealing wound: the association of polio and skin cancer. Arch Dermatol. 2007 Oct; 143(10):1338-9. PMID: 17938358.
      Citations:    Fields:    Translation:Humans
    11. Duvic M, Vu J. Vorinostat in cutaneous T-cell lymphoma. Drugs Today (Barc). 2007 Sep; 43(9):585-99. PMID: 17940636.
      Citations: 15     Fields:    Translation:HumansAnimals
    12. Duvic M, Vu J. Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma. Expert Opin Investig Drugs. 2007 Jul; 16(7):1111-20. PMID: 17594194.
      Citations: 120     Fields:    Translation:HumansAnimals
    13. Vu J, Wallace GR, Singh R, Diwan H, Prieto V, Rady P, Tyring S, Duvic M. Common variable immunodeficiency syndrome associated with epidermodysplasia verruciformis. Am J Clin Dermatol. 2007; 8(5):307-10. PMID: 17902733.
      Citations:    Fields:    Translation:HumansCells
    POZADZIDES's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (106)
    Explore
    _
    Co-Authors (30)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _